Adam Pang Named Chief Revenue Officer; Chris LaGullo Named Chief Operating Officer

Proven Industry Leaders to Drive Unimed’s Continued Growth and Innovation as the Premier Provider of Pharmaceutical and Medical Solutions to the Global Maritime Industry

Universal Marine Medical Supply International (“Unimed” or the “Company”), the leading global provider of pharmaceutical and medical solutions to the maritime industry, today announced the expansion of its senior management team with the additions of Adam Pang as Chief Revenue Officer and Chris LaGullo as Chief Operating Officer.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241210976538/en/

(Graphic: Business Wire)

Mr. Pang and Mr. LaGullo reinforce Unimed’s commitment to delivering exceptional value to its global customers while positioning the Company for long-term success. With decades of leadership experience, these additions bring a wealth of expertise in driving growth, operational efficiency, and innovation across complex industries. Their contributions will be instrumental in advancing Unimed’s mission to elevate health care solutions in the maritime industry.

“We are thrilled to welcome two exceptional leaders whose expertise will help shape the future of Unimed,” said Søren Andersen, CEO of Unimed. “With their deep industry experience and proven track records, Adam and Chris are uniquely positioned to help us elevate the standard of medical care across the maritime industry. These appointments underscore our commitment to operational excellence, customer-centric innovation, and continued growth. Together, they will play a pivotal role in driving Unimed’s missions to deliver high-quality, technology-driven solutions that meet the complex needs of our global clients.”

Mr. Pang and Mr. LaGullo bring decades of leadership experience in driving growth, innovation, and operational excellence within complex and evolving industries.

“Adam and Chris are recognized as leaders who excel at scaling organizations, managing complexity, and fostering innovation,” said James Zenni, Founder, President and Chief Executive Officer of ZCG. “Their expertise will be instrumental in advancing Unimed’s strategic goals and expanding its reach. With these appointments, Unimed is even better positioned to capitalize on emerging opportunities, deliver unmatched service to its global client base, and build a sustainable foundation for the future.”

Mr. Pang joins Unimed with more than two decades of leadership experience, specializing in driving significant revenue growth and digital transformation in high-growth, entrepreneurial environments. Most recently, he served as Chief Commercial Officer to Lloyd’s Register, where he was instrumental in enhancing market presence and advancing digital capabilities following the successful acquisition of OneOcean, a SaaS business serving the maritime sector. As Chief Revenue Officer, Mr. Pang will focus on leveraging technology and data-driven insights to drive sales, enhance customer engagement, and support Unimed’s long-term growth strategy.

“Joining Unimed as Chief Revenue Officer presents an incredible opportunity to be part of shaping the future of health care solutions for the maritime industry,” Mr. Pang said. “I am eager to collaborate with the talented teams at Unimed and ZCG to drive innovation and create new opportunities for growth that benefit our customers worldwide.”

With 25 years of experience in logistics within the pharmaceutical industry, Mr. LaGullo will oversee Unimed’s global operations, focusing on enhancing efficiency, performance, and service innovation. Previously, he served as Vice President of Americas Logistics at Marken, a UPS subsidiary specializing in specialty courier services. There, he successfully implemented lean operational processes and developed organizational and training initiatives to improve efficiency and elevated service delivery.

“I am pleased to serve as Chief Operating Officer of Unimed at such a dynamic time in the maritime industry,” Mr. LaGullo said. “Unimed has established itself as a highly respected leader in the space, and I look forward to identifying new ways to ensure operational excellence so that Unimed is positioned to consistently exceed our customers’ expectations, drive impactful growth overall, and deliver exceptional value to all our stakeholders.”

About Unimed

Unimed is the industry leader in medical supply, equipment and oxygen distribution to global maritime industries, specializing in the delivery of integrated healthcare and safety supply chain logistical solutions to clients worldwide.

Unimed is a portfolio company of ZCG Private Equity, the private equity arm of ZCG (www.zcg.com), a leading privately held merchant bank comprised of private markets asset management, business consulting services, and technology development and solutions.

For more information, please visit https://universalmarinemedical.com/.

About ZCG

ZCG is a leading, privately held merchant bank comprised of three dynamic, cross-disciplinary platforms: private markets asset management, business consulting services, and technology development and solutions.

ZCG’s investors are some of the largest and most sophisticated global institutional investors including pension funds, endowments, foundations, sovereign wealth funds, central banks, and insurance companies.

For almost 30 years, ZCG Principals have invested tens of billions of dollars of capital.

ZCG has a global team comprised of approximately 400 professionals. The company is headquartered in New York, with affiliate offices located in Pune and Mumbai, India, and Riyadh, KSA. For more information on ZCG, please visit www.zcg.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241210976538/en/